<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated whether combined treatment with <z:chebi fb="0" ids="9086">selegiline</z:chebi>, a selective MAO-B inhibitor, and EGb 761, a standard extract of Ginkgo biloba, has synergistic effects against ischemic reperfusion injury (IRI) in gerbils </plain></SENT>
<SENT sid="1" pm="."><plain>Interestingly, we observed that pretreatment with EGb 761 significantly attenuated <z:chebi fb="0" ids="9086">selegiline</z:chebi>-induced <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This finding paralleled striatal fos-related antigen immunoreactivity (FRA-IR) in mice </plain></SENT>
<SENT sid="3" pm="."><plain>Four minutes of bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> caused substantial cell loss in the CA1 of the hippocampus 5 days post-ischemic insult </plain></SENT>
<SENT sid="4" pm="."><plain>Pretreatment with EGb 761, with or without <z:chebi fb="0" ids="9086">selegiline</z:chebi>, significantly attenuated this <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Combined treatment with EGb 761 plus <z:chebi fb="0" ids="9086">selegiline</z:chebi> was more efficacious in preventing this loss </plain></SENT>
<SENT sid="6" pm="."><plain>Synaptosomal formations of protein <z:chebi fb="1" ids="23019">carbonyl</z:chebi>, <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation (malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) + 4-hydroxyalkenal (4-HDA)), and reactive oxygen species (ROS) in the hippocampus remained elevated 5 days post-ischemic insult </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:chebi fb="11" ids="22586">antioxidant</z:chebi> effects appeared to be most significant in the group treated with EGb 761 plus <z:chebi fb="0" ids="9086">selegiline</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>This combined treatment produced more significant attenuation of IRI-induced alterations in intramitochondrial calcium accumulation, the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> transmembrane potential, and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> Mn-<z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase-like immunoreactivity (Mn-SOD-IR) than either treatment alone </plain></SENT>
<SENT sid="9" pm="."><plain>Our results suggest that co-administration of EGb 761 and <z:chebi fb="0" ids="9086">selegiline</z:chebi> produces significant neuroprotective effects via suppression of <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction without affecting neurological function </plain></SENT>
</text></document>